The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

From unexpected gender disparities to alarming teen statistics, discover essential facts about opioid medications that every ...

The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx ...

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to local medical professionals. "I think it could be a potentially ...

The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...